Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Sio Gene Therapies Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 38 | 1 | 37 | 0 |
| Shares | 21.1M | 146.5K | 18.6M | −2.37M (−11.3%) |
| Value | $5.91M | $41.0K | $8.09M | +$2.22M (+37.8%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Sio Gene Therapies Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 2,000,000 | $870.0K | 0.13% |
| JBF Capital, Inc. | 429,600 | $186.9K | 0.05% |
| Western Standard LLC | 294,397 | $128.1K | 0.11% |
| Susquehanna International Group, LLP | 95,387 | $41.5K | 0.00% |
| Citadel Advisors LLC | 15,202 | $6.61K | 0.00% |
| StoneX Group Inc. | 13,913 | $6.05K | 0.00% |
Sold out (6)
Institutions that held Sio Gene Therapies Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Suvretta Capital Management, LLC | 5,914,000 | $1.66M |
| Jane Street Group, LLC | 99,324 | $28.0K |
| Boston Private Wealth LLC | 94,150 | $26.0K |
| Verition Fund Management LLC | 20,000 | $6.00K |
| Hudock, Inc. | 179 | $0 |
| TCI Wealth Advisors, Inc. | 400 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Sio Gene Therapies Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ACT Capital Management, LLC | 146,500 | $41.0K |